Development and Pilot Testing of a Cognitive-Behavioral Therapy Digital Service for Body Dysmorphic Disorder.


Journal

Behavior therapy
ISSN: 1878-1888
Titre abrégé: Behav Ther
Pays: England
ID NLM: 1251640

Informations de publication

Date de publication:
01 2020
Historique:
received: 25 10 2018
revised: 14 01 2019
accepted: 08 03 2019
entrez: 2 2 2020
pubmed: 2 2 2020
medline: 11 8 2020
Statut: ppublish

Résumé

Body dysmorphic disorder (BDD) has a severe presentation and chronic course when untreated. Although effective BDD treatments exist, most individuals do not have access to them. We therefore developed and pilot tested the first smartphone-delivered individual cognitive-behavioral therapy (CBT) treatment for adults with BDD. The digital service was developed via user-centered design, integrating input from engineering, design, and psychology experts, plus BDD patient consultants. We conducted a 12-week open pilot trial (N = 10) to describe preliminary results for feasibility, acceptability, and treatment outcome. Attrition rates (0%) and feedback on usability and satisfaction indicated that smartphone-based CBT for BDD may be feasible, acceptable, and satisfactory. Initial results suggest that smartphone-based CBT for BDD may hold promise for improving BDD symptom severity, BDD-related insight, functional impairment, and quality of life, as scores from baseline to posttreatment improved with large-to-very large effects; depression improved with a medium effect. Ninety percent of participants were responders at posttreatment and 3-month follow-up. Smartphone-based CBT for BDD may have strong potential as a standardized, low cost, and accessible treatment for this debilitating illness. A test of efficacy is merited as a next step, using a well-powered, randomized control trial design.

Identifiants

pubmed: 32005333
pii: S0005-7894(19)30096-6
doi: 10.1016/j.beth.2019.03.007
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT03221738']

Types de publication

Clinical Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

15-26

Informations de copyright

Copyright © 2019. Published by Elsevier Ltd.

Auteurs

Sabine Wilhelm (S)

Massachusetts General Hospital/Harvard Medical School. Electronic address: swilhelm@mgh.harvard.edu.

Hilary Weingarden (H)

Massachusetts General Hospital/Harvard Medical School.

Jennifer L Greenberg (JL)

Massachusetts General Hospital/Harvard Medical School.

Thomas H McCoy (TH)

Massachusetts General Hospital/Harvard Medical School.

Ilana Ladis (I)

Massachusetts General Hospital/Harvard Medical School.

Berta J Summers (BJ)

Massachusetts General Hospital/Harvard Medical School.

Aleksandar Matic (A)

Telefónica Innovación Alpha, S.L.

Oliver Harrison (O)

Telefónica Innovación Alpha, S.L.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH